PODXL has been shown to increase the invasive and migratory potential of MCF7 breast cancer and PC3 prostate cancer cells in vitro and leads to an increase in mitogen-activated protein kinase and phosphatidylinositol 3-kinase activity [67]. Here, PODXL is linked to prostate cancer.